Organogenesis Holdings (ORGO) Receivables - Net (2017 - 2025)
Historic Receivables - Net for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $182.2 million.
- Organogenesis Holdings' Receivables - Net rose 6416.28% to $182.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.2 million, marking a year-over-year increase of 6416.28%. This contributed to the annual value of $119.4 million for FY2024, which is 3441.18% up from last year.
- According to the latest figures from Q3 2025, Organogenesis Holdings' Receivables - Net is $182.2 million, which was up 6416.28% from $131.5 million recorded in Q2 2025.
- Organogenesis Holdings' Receivables - Net's 5-year high stood at $182.2 million during Q3 2025, with a 5-year trough of $72.0 million in Q1 2021.
- In the last 5 years, Organogenesis Holdings' Receivables - Net had a median value of $98.7 million in 2022 and averaged $102.7 million.
- In the last 5 years, Organogenesis Holdings' Receivables - Net surged by 10040.92% in 2021 and then crashed by 725.69% in 2023.
- Over the past 5 years, Organogenesis Holdings' Receivables - Net (Quarter) stood at $87.6 million in 2021, then increased by 9.36% to $95.8 million in 2022, then dropped by 7.26% to $88.9 million in 2023, then skyrocketed by 34.41% to $119.4 million in 2024, then soared by 52.57% to $182.2 million in 2025.
- Its Receivables - Net was $182.2 million in Q3 2025, compared to $131.5 million in Q2 2025 and $112.4 million in Q1 2025.